Literature DB >> 2796713

Sutureless microvascular anastomosis using the THC:YAG laser: a preliminary report.

L S Bass1, M R Treat, C Dzakonski, S L Trokel.   

Abstract

Laser anastomosis of the rat carotid artery was performed using a new mid-infrared laser, the pulsed thulium-holmium-chromium: YAG (THC:YAG) laser (2.15 microns). Solid silicone stents made stay sutures unnecessary for coaptation of vessel edges during laser bonding. Grossly, the laser anastomoses displayed minimal thermal distortion of the vessel contour and no tissue carbonization. Of the 30 anastomoses performed, 27 were patent and 3 had separation of the weld shortly after the approximator clamp was released. Mean anastomotic time was 4 min 48 sec. Mean bursting pressure for the 9 vessels tested was 400 mm Hg. Thrombosis did not occur at any time during our examination of these anastomoses. Fusion of collagen fibers in the media was confirmed histologically. Unlike the CO2 laser, the THC:YAG is transmissible through flexible silica fibers, which greatly facilitates delivery of the laser in a microsurgical operative field. The THC:YAG provides shallower absorption depth than Nd:YAG and argon lasers but somewhat deeper tissue penetration than CO2. For microvessels, this intermediate absorption results in full-thickness fusion of the media, with minimal thermal damage to vascular tissue adjacent to the anastomosis.

Entities:  

Mesh:

Year:  1989        PMID: 2796713     DOI: 10.1002/micr.1920100309

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  2 in total

1.  Laser welding of vesicovaginal fistula--outcome analysis and long-term outcome: single-centre experience.

Authors:  Prem N Dogra; Ashish K Saini
Journal:  Int Urogynecol J       Date:  2011-03-25       Impact factor: 2.894

Review 2.  Emerging Data on Fistula Laser Closure (FiLaC) for the Treatment of Perianal Fistulas; Patient Selection and Outcomes.

Authors:  Samuel O Adegbola; Kapil Sahnan; Phillip Tozer; Janindra Warusavitarne
Journal:  Clin Exp Gastroenterol       Date:  2021-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.